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Laser ablation inductively coupled plasma mass spectrometry (LA-ICP-MS) has been estab-
lished as a powerful technique for the determination of metal and nonmetal distributions
within biological systems with high sensitivity. An imaging LA-ICP-MS technique for Fe, Cu,
Zn, and Mn was developed to produce large series of quantitative element maps in native brain
sections of mice subchronically intoxicated with 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridin
(MPTP) as a model of Parkinson’s disease. Images were calibrated using matrix-matched
laboratory standards. A software solution allowing a precise delineation of anatomical structures
was implemented. Coronal brain sections were analyzed crossing the striatum and the substantia
nigra, respectively. Animals sacrificed 2 h, 7 d, or 28 d after the last MPTP injection and controls
were investigated.
We observed significant decreases of Cu concentrations in the periventricular zone and the
fascia dentata at 2 h and 7d and a recovery or overcompensation at 28 d, most pronounced in
the rostral periventricular zone (40%). In the cortex Cu decreased slightly to 10%. Fe
increased in the interpeduncular nucleus (40%) but not in the substantia nigra. This pattern
is in line with a differential regulation of periventricular and parenchymal Cu, and with the
histochemical localization of Fe, and congruent to regions of preferential MPTP binding
described in the rodent brain.
The LA-ICP-MS technique yielded valid and statistically robust results in the present study
on 39 slices from 19 animals. Our findings underline the value of routine micro-local analytical
techniques in the life sciences and affirm a role of Cu availability in Parkinson’s
disease. (J Am Soc Mass Spectrom 2010, 21, 161–171) © 2010 American Society for Mass
SpectrometryMetal ions are assumed to contribute criticallyto the pathophysiology and pathogenesis ofneurodegenerative diseases such as Parkin-
son’s disease (PD) and Alzheimer’s disease [1–4]. Cel-
lular redox imbalance is currently considered to be a
major step in the mechanistic cascade leading to cell
death [5]. The imbalance consists unanimously in a
lower (more negative) cellular redox potential, which is
most pronounced in the inner mitochondrial compart-
ment with an increase in the ratio NADH/NAD. In
this scenario, metal cations are protagonists in the active
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doi:10.1016/j.jasms.2009.09.022center of almost all redox active enzymes, as compo-
nents of redox buffer systems, as parts of oxygen
transporting globins, and as toxic species like Fe2 and
Cu catalyzing radical formation. Mn is known to cause
Parkinsonism in primates [6].
A series of studies measured metal concentrations in
tissue homogenates of PD brains. With respect to the
situation in situ, knowledge has largely been restricted
to histochemical stainings of Fe using variations of the
Prussian blue reaction [4, 7], labeling free Fe2/Fe3
and different fractions of bound or precipitated Fe2/
Fe3 depending on the precise experimental conditions,
which is a parameter distinct from the total Fe content.
Popescu and coworkers only recently imaged Fe, Cu,
and Zn in the midbrain and basal ganglia of a control
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rescence (SRXRF) [8]. Several other studies assessed PD
samples using high-resolution techniques with a lim-
ited field of view such as high-resolution SRXRF [9, 10].
All these techniques have difficulty in acquiring reliable
quantitative data.
In recent years, laser ablation inductively coupled
plasma mass spectrometry (LA-ICP-MS) has been de-
veloped as the method of choice for the quantitative
imaging of elements (especially metals) in biological
tissues. LA-ICP-MS imaging of native cryo-sections
(optimum at 20–30 m thickness) has been introduced
and developed into a sensitive routine technique in
Becker’s laboratory at Forschungszentrum Jülich [11–
23]. LA-ICP-MS offers a fast and precise spatially re-
solved measurement of elements in situ at the trace and
ultratrace level, including isotope ratios with high ana-
lytical throughput and minimal sample preparation at
reducedmass spectral interferences. For the quantification
of LA-ICP-MS data, strategies using well-prepared homo-
geneousmatrix-matched laboratory standards were estab-
lished at Forschungszentrum Jülich [11–19, 22–24].
Concerning the choice of samples, it should be noted
that the most widely studied neurotoxin animal models
for PD are based on local injections of 6-hydroxy-
dopamine (6-OHDA, Scheme 1) in the nigrostriatal
system in rodents, or systemic application of 1-methyl-
4-phenyl-1,2,3,6-tetrahydropyridin (MPTP, Scheme 1)
mostly in monkeys or mice.
MPTP was accidentally discovered as a contamina-
tion of the illicit opioid meperidine causing a long-
lasting Parkinsonian syndrome in humans replicating
Scheme 1. Structure of the proto-toxin 1-methy
this study, its metabolic activation to MPP,
neurotoxin 6-hydroxydopamine (6-OHDA), an
carbamate and clioquinol.most features of sporadic PD. The pro-toxin MPTP is
oxidized by the monoamine oxidase B (MAO-B), local-
ized within glia to its active metabolite MPP, which is
then selectively incorporated into dopaminergic neu-
rons via the membrane bound dopamine transporter
(Scheme 1) [25]. As a basic lipophilic compound, it is
further enriched within the lipid compartment of the
inner mitochondrial membrane where it exerts an effect
as a strong and selective inhibitor of Complex I of the
respiratory chain. Additional mechanisms of toxicity
may be involved. The MPTP model led to a tremendous
insight into the mechanisms of neuronal cell death in
PD [26, 27]. Recently, Hare et al. [28] presented an
approach for measuring in situ metal distributions in
three unilaterally 6-OHDA lesioned mice and two sec-
tions of one control by LA-ICP-MS.
The aim of the present study was to develop imaging
LA-ICP-MS of metals into a routine scale technique and
to apply it to a larger statistically representative series
of samples. A new software solution allowed the ana-
tomically precise delineation of regions of interest and
enabled the kinetics of metal concentrations to be mea-
sured after subchronic treatment with MPTP. An addi-
tional aim was to employ the established LA-ICP-MS
imaging techniques for further understanding of the
general metallo-architecture of the mouse brain.
Experimental
The basic workflow of elemental imaging LA-ICP-MS
using a quadrupole-based ICP-MS coupled to the laser
ablation system (from sample preparation via scanning
henyl-1,2,3,6-tetrahydropyridin (MPTP) used in
structures of the compounds discussed, the
the protective copper chelators diethyldithio-l-4-p
and
d of
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ments of ion signals) is illustrated in Figure 1.
LA-ICP-MS Instrumentation
LA-ICP-MS measurements were performed using a
quadrupole-based inductively coupled (ICP) mass spec-
trometer (ICP-QMS, Agilent 7500, Tokyo, Japan) cou-
pled to a laser ablation system (NewWave UP 266, New
Wave, Fremont, CA, USA). The material was ablated by
a focused Nd:YAG laser and then transported by argon
as carrier gas into the inductively coupled plasma (ICP).
After ion formation in the ICP ion source, the positively
charged ions were extracted from the argon plasma
(at100 kPa) via the differentially pumped interface (at
130 Pa) between the sampler and skimmer cones into
the high vacuum of the quadrupole mass analyzers, and
were separated with respect to their mass-to-charge
ratios and detected by the ion detector. The experimen-
tal parameters of LA-ICP-MS were optimized with
respect to the maximum ion intensity of 63Cu using a
well-homogenized synthetic laboratory standard. Max-
imum ion intensity was observed at an rf ICP power of
1500 W and a carrier gas flow rate of 1.2 L min1.
During two-dimensional (2D) imaging of brain tissues,
a defined sample area (several cm2) of a thin section of
brain tissue (thickness: 14 m) was ablated line by line
with a focused laser beam. A spot size of the laser beam
of 120 m, a laser power density of 1 109 W cm2 and
a repetition frequency of 20 Hz were selected. The ion
intensities of the analytes, e.g., of 64Zn, were measured
by LA-ICP-MS line by line at a scan speed of 30 m s1
in the raster mode throughout the entire ca. 9 mm 6mm
brain section. All mass spectrometric measurements were
Figure 1. Experimental workflow of the imagi
MPTP was applied to mice, brains were removed
ablated by a focused laser beam in the laser ab
mass-spectrometrically, and metal ion images were coperformed with established protocols in routine mode in
Becker’s BrainMet laboratory (BrainMet–Bioimaging of
Metals in Brain and Metallomics) at Forschungszentrum
Jülich [11–24]. Optimized experimental parameters are
summarized in Table 1.
Calibration Procedure
The properties of LA-ICP-MS allow an easy quantifica-
tion of the measured elements. The distribution profiles
of the metals of interest in the brain sections obtained
by LA-ICP-MS were quantified using matrix-matched
synthetic laboratory standards. Synthetic laboratory
standards were prepared from brain homogenates of
analogous control mice doped with trace elements of
defined concentrations [11, 12]. Milli-Q water or stan-
dard solutions with known concentration of analytes
ass spectrometric technique using LA-ICP-MS.
cryo-cut as scheduled. A thin tissue section was
n chamber, the ablated material was analyzed
Table 1. Optimized experimental parameters of LA-ICP-MS
ICP-MS ICP-QMS Agilent 7500 ce
RF power 1500 W
Carrier gas flow rate 1.2 L min1
Mass resolution m/m 300
Laser ablation system NewWave UP 266
Wavelength of Nd:YAG laser 266 nm
Ablation mode Scanning (line per line)
Laser pulse duration 20 ns
Repetition frequency 20 Hz
Laser power density 109 W cm2
Number of passes 1
Energy output 50%
Scan speed 30 m s1
Laser beam diameter 120 m
Distance between lines 10 mng m
and
lationstructed, quantified, and analyzed regionally.
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concentrations of metals in the lab standards were 0,
1.2, 2.9, 5.9, 9.2, 12.6, 31, 56, 93, and 110 g g1 of 24
elements. The final concentrations of these standards
were validated by ICP-MS after microwave-induced
digestion with HNO3 and H2O2. These homogeneous
lab standards were frozen, cryo-cut into slices, and
mounted onto glass slides together with the sample
tissue and utilized for the quantification of LA-ICP-MS
data in imaging brain tissues in routine mode. Matrix-
matched standards were used to constitute calibration
curves, whereas the regression coefficient of the calibra-
tion curves obtained was typically 0.9 as described
previously [12, 15]. To validate the ion images, at least
two isotopes, if available, (e.g., 63Cu and 65Cu or
64Zn and 66Zn) were analyzed, and the elemental dis-
tribution in neighboring tissue slices was performed un-
der the same experimental parameters. Possible isobaric
interferences of single-charged analyte ions with poly-
atomic ions or double-charged ions were studied carefully
and minimized under optimum experimental conditions.
Data Treatment
No commercial software is currently available to eval-
uate analytical LA-ICP-MS data for the imaging of
elements. We developed software packages with the
aim of obtaining three-dimensional (3D) metal or non-
metal distributions, e.g., in mouse or rat brain, to correlate
the data with MRI (magnet resonance images) immuno-
stained, autoradiographic, and histochemical images of
the same rat brain at Forschungszentrum Jülich.
The data output from the mass spectrometer was
organized in columns of signal values at consecutive
time points for every element in a single ASCII file.
These lists of measurements were transformed into an
image of element count rates to visualize their spatial
distribution using a software tool written in-house. The
software takes into account parameters such as line
length, number of lines, data offset at start and at end,
as well as the diameter of the laser beam and the
distance between the lines. The pixel size of the result-
ing images is determined according to the highest
common factor of line distance and spot diameter.
Values between scanned lines are filled by linear inter-
polation in the y-direction. The range of values to be
displayed in an 8-bit graphic was chosen from the
lowest pixel value to the highest biological value, dis-
regarding data artifacts out of the sample area. The
reconstructed element image was exported as 8-bit
grayscale TIFF file and optionally as a color image after
pseudo-coloring with a rainbow color map. Further
treatment of the images in terms of calibration and
region-of-interest (ROI) selection was done with Pmod
version 2.95 (Pmod, Zürich, Switzerland).
Precise anatomical ROIs were delineated according
to the corresponding plane from the Paxinos’ and
Franklin mouse brain atlas [29] integrating the topo-
graphical information from Zn, Cu, Fe, Mn, C, and Pmaps and from adjacent sections stained with cresyl
violet. The entire brain area was covered by regions.
The average signal was computed in each freely drawn
region. Finally, the raw images were scaled after sub-
traction of the averaged glass offset, thus yielding
parametric images of element concentrations. The lin-
earity of the data conversion was verified.
Absolute calibrations were available for 14 of the 39
sections. In the remaining images, the signal was nor-
malized to the average of a reference region. The
reference region was the corpus callosum for most
elements. In Cu images, the corpus callosum was out-
shined too much by the extremely high Cu signal of the
adjacent sub- and periventricular zone, therefore, cortex
layer II and III proved as better reference regions. In
some Fe images, the upper third of an image, including
the corpus callosum, showed a signal drift. Therefore, a
reference region at the same vertical height as the most
interesting SN and with comparatively low Fe signal was
chosen, including ventral neo- and archicortical areas. The
background signal, averaged from the blank glass sur-
rounding was subtracted from each regional signal.
A univariate one-way analysis of variance (ANOVA)
was used to compare the means of regional element
concentrations between the groups control, 2 h, 7 d, and
28 d post-MPTP. P values as the level of significance
indicate the probability that within-group variances
equal between-group variances. Upon the a-priori hy-
pothesis that kinetics after the intervention are an
increase, a decrease, or follow a u-shape, corresponding
contrasts were tested. A P  0.05 was considered as
significant. The SPSS version 17.0 software (SPSS Inc.,
Chicago, IL, USA) was used for statistics.
Animal Experiment and Sample Preparation
All animal experiments were approved by the local
authorities (Regierungspräsidium Gießen) and were
performed in accordance with current guidelines. Wild-
type C57Bl6 male mice, 8 to 10 wk old, were injected
with 30 mg kg1 MPTP (3 mg mL1 saline) or vehicle
intra-peritoneally on 5 consecutive d according to [27, 30].
Animals were sacrificed 2 h, 7 d, or 28 d after the last
injection using 100 mg kg1 pentobarbital and immedi-
ately perfused with saline. Time points were chosen to
best represent the pathologic stages of ongoing degener-
ation (2 h), maximal degeneration (7 d), stable lesion and
astrogliosis (28 d). Brains were removed and frozen in
isopentane at 78.5 °C. Cryosections of brains and stan-
dards of 14 m thickness were mounted on silanized
slides. Neighboring sections were stained with cresyl
violet.
Characterization of the MPTP Model
Dopamine within striatal fragments dissected from an-
imals treated in parallel within the same experiment
was quantified by high-pressure liquid chromatogra-
phy (HPLC) with electrochemical detection. Briefly, the
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N) for 1 min. After centrifugation at 13,000 g and 4 °C,
the supernatants were passed through a 0.2 m filter; 20
L aliquots were injected by an autosampler cooled at
4 °C on a Knaur Nucleosil 120 Å C18 column (250  4
mm, precolumn 5  4 mm; Knaur, Berlin, Germany)
maintained at 45 °C by a column oven. Isocratic elution
at 0.5 mL min1 used acetonitrile/water 3.5/97.5 con-
taining 0.6% triethanolamine adjusted to pH 2.95 with
phosphoric acid 100 mg L1 Na2EDTA and 140 mg L
1
octane-sulfonic acid. The detector potential of a glassy
carbon electrode was set to 750 mV against an Ag/AgCl
reference electrode. Chromatograms were recorded and
analyzed by the HPLC computer system Chromeleon
(Dionex, Germany).
Immunohistochemistry was carried out on free-
floating paraformaldehyde-fixed and sucrose-protected
brain cryo-sections with a polyclonal antibody against
tyrosine hydroxylase (TH; Chemicon, Germany), using
standard avidin-biotin-peroxidase techniques (Vectastain
Elite ABC kit; Boehringer, Germany) and visualized enzy-
matically by incubation with 3,3=-diaminobenzidine (DAB;
Sigma-Aldrich, St. Louis, MO, USA), enhanced by the
addition of nickel ammonium sulfate (Fluka, Buchs,
Switzerland), resulting in a dark blue staining [31]. The
number of TH neurons within the substantia nigra
was determined on several sections per animal.
Results and Discussion
New Achievements in LA-ICP-MS Imaging
Techniques
The reproducibility of the imaging LA-ICP-MS tech-
nique for the analysis of 20 m thin cross sections of
Figure 2. Nigrostriatal dopaminergic pathway
characterized by antibody staining for tyrosin
biosynthesis and a marker of dopaminergic neur
later a partial recovery of dopaminergic fibers
dopaminergic neurons occurred in the substan
sections.biological tissues was studied by Becker and coworkers
[21]. A reproducibility of about 3% had been observed
for homogeneous tissues (e.g., thin sections of matrix-
matched laboratory standards) and a reproducibility in
the range of 5%–7% for inhomogeneous tissues (adja-
cent sections of inhomogeneous human brain) compar-
ing the distribution of the elements of interest. In the
present study, replicate measurements of two or three
adjacent sections were highly reproducible with coeffi-
cients of variation of 5% for Fe and Cu, 12% for Zn, and
11% for Mn in the striatum.
In the present study, quantitative images of metals
were obtained in brain slices from mice in a time course
series after intoxication with MPTP. Sections at an
anterior level crossed the striatum and those at a
posterior level crossed the hippocampus and the sub-
stantia nigra, thus covering the most relevant structures
for PD research. The subchronic MPTP intoxication
paradigm induced a homogeneous and reproducible
degeneration of the nigrostriatal dopaminergic neuro-
nal projection as indicated by a considerable and par-
tially reversible decrease in nerve fibers in the striatum
(Figure 2a) and in striatal dopamine levels (Table 2)
compared with saline-treated controls. The number of
TH immunostained neurons in the substantia nigra
decreased irreversibly (Figure 2b, Table 3). TH is the
key enzyme of the dopamine biosynthesis and the most
widely used marker for dopaminergic neurons and
terminals that are selectively hit by MPTP.
We implemented in-house software to reveal the
spatial distribution of LA-ICP-MS data followed by a
comprehensive data analysis utilizing atlas-related free-
form ROIs, calibration, and statistical analysis by com-
mercially available image analysis and statistics soft-
y induced by subchronic MPTP treatment was
roxylase (TH), the key enzyme of dopamine
nd fibers. (a) A considerable early decrease and
red in the striatum. (b) An irreversible loss of
igra. Shown are photomicrographs of coronalinjur
e hyd
ons a
occur
tia n
comp
 0.0
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for each section based upon the topographic informa-
tion provided by images of Zn, Cu, Fe, Mn, C, and P
by cresyl-violet-stained adjacent sections in conjunc-
tion with the corresponding plane of the mouse brain
atlas [29].
LA-ICP-MS imaging yielded a highly reproducible
architecture of element distributions in line with previ-
ous findings by others and ourselves [7, 13, 28]. On the
basis of maps of Fe, Zn, Cu, Mn, C, and P, it was
possible to define a consistent set of ROIs precisely
matching the topography revealed by cresyl-violet
stains (Figure 3).
Metallo-Architecture in the Normal Mouse Brain
Examples of element maps of coronal sections at an
anterior plane and a posterior plane are shown in
Figures 4 and 5 for each condition. The location of the
highest Fe concentration was the interpeduncular nu-
cleus followed by the dorsal and ventral pallidum. This
was in line with modified Prussian blue stainings of rat
brains [7]. Cortical Fe was concentrated in the outer and
inner granular layer (II and IV), whereas Fe was low in
the inner pyramidal layer V and the multiform layer
Table 2. Concentrations of Fe, Cu, Zn, Mn measured by imagin
element in the brain of mice (18 animals) at different time points
characterizing the lesion to the dopaminergic system are given: t
immunostaining (TH) within the substantia nigra reflecting the
measured by HPLC of extracts from striatal tissue reflecting the p
g g-1 wet weight Control M
Fe
Interpeduncular 4.5  0.7 5
Cu
Periventricular 8.9  2.2 7
Aquaeduct 5.0  1.2 4
Ventral FD 4.6  0.8 3
Dorsal FD 2.2  0.3 1
Presubiculum 2.6  0.4 2
Zn
CA3/PolDG 25.6  3.9 22
Dorsal FD 9.5  1.7 8
Piriform CTX 8.3  0.8 9
Mn
Ncl. Ruber 0.36  0.05 0.
Nigral TH-cell count 9459  537 62
Striatal Dopamine concentration g g1 22.5  2.9 5
Data are given as mean  standard deviation.
- 	 not significant; ANOVA 	 analysis of variance; CTX 	 cortex; FD 	 f
TH 	 positive for tyrosine hydroxylase immunostaining.
*A univariate one-way analysis of variance was used to compare gr
within-group variances equal between-group variances. P  0.05 was
**Level of significance yielded from the contrast (1, 1, 1, 1) assum
***The P value for nigral cell counts was P 	 0.00000009 resulting from
significantly (P  0.000006) higher values in the control group comp
compared with 28 d (P 	 0.04).
****The P value for striatal dopamine concentrations from parallel anim
yielded significantly (P  0.0004) higher values in the control group
concentrations at 28 d significantly exceeded values at 2 h and 7 d (P(IV). The Cu concentration was highest in the periven-tricular zones, exceeding the cortex and basal ganglia
by a factor of 5. Other regions of elevated Cu concen-
trations were the ventral (factor 3) and dorsal fascia
dentata (granular layer), the supramamillar nucleus
and the presubiculum (factor 1.5). Cu allowed a clear
delineation of the cornu ammonis, the striatum and
cortical layers.
Zn was clearly most concentrated in the portion of
CA3 belonging to the dentate gyrus (polymorph
layer) followed by the rest of CA3, the amygdala, the
piriform cortex, and cortical layer I. In comparison,
Zn concentrations were extremely low in other areas.
High Mn was observed in the medial hypothala-
mus, in the nucleus ruber, in the accessory oculomo-
tor nucleus, and, to a lesser extent, in the substantia
nigra.
Mg was almost homogenously distributed with
slight systematic enrichments in areas of high cell
density, such as the fascia dentata or distinct cortical
layers, and in white matter. Na and K showed a
homogeneous distribution (data not shown).
As in our previous studies C, P, and S showed slight
but consistent elevations in white matter corresponding
to the lower water content of 70% compared with 80%
in gray matter. In addition, for sulfur a modest enrich-
-ICP-MS in selected regions of interest characteristic of each
MPTP treatment versus controls. For comparison measures
tal count of cells positive for tyrosine hydroxylase
ersible lesion to cell bodies and dopamine concentrations
lly reversible lesion to neuronal terminals
2 h MPTP 7 d MPTP 28 d
ANOVA
P* global P** increase
1.0 6.2  0.8 6.2  1.5 - 0.025
1.0 7.9  1.1 12.3  4.2 0.008 -
0.2 5.9  1.9 5.8  2.4 - -
0.6 5.2  1.0 4.5  1.0 0.001 0.005
0.2 2.4  0.4 2.2  0.5 0.031 0.07
0.2 2.6  0.4 2.3  0.5 - -
1.9 25.3  2.1 27.0  4.8 0.038 0.07
1.0 9.3  1.4 9.3  0.9 - -
1.2 8.6  1.4 9.3  1.5 - -
0.02 0.35  0.01 0.36  0.09 - -
466 5227  319 5148  600 0.001 ***
0.7 7.8  0.7 14.3  2.2 0.001 ****
dentata; Ncl 	 nucleus; PolDG 	 polymorph layer of the dentate gyrus;
eans. P values as level of significance indicate the probability that
dered as significant.
two-step increase in the order Ctrl 	 2h  7d 	 28 d.
al ANOVA. Post hoc Bonferroni tests for multiple comparisons yielded
to all other groups and in addition significantly higher values at 2 h
as P 	 0.00000010. Post hoc Bonferroni tests for multiple comparisons
ared wit all other groups. In addition, partially recovered dopamine
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Average concentrations of Fe, Cu, Zn, and Mn through-
out different regions in control animals and in animals
sacrificed at different time points after MPTP are given
in Tables 2 and 3 in parallel with the time course of the
dopaminergic lesion (Table 3). Significant results from
one-way ANOVA are indicated. Figures 4 and 5 illus-
trate findings by quantitative element maps from a
representative section of each group.
The highest change observed was a 38% increase
versus the control of Cu at 28 d following a roughly 10%
decrease at 2 h and 7 d in the periventricular zone. In
the fascia dentata, a significant initial 17% and 27%
(dorsal and ventral) decrease at 2 h was followed by a
compensatory increase to control level at d 7 and 28.
The common motif of these asynchronous kinetics was
a decrease followed by a compensation or overcompen-
sation. In contrast, cortical Cu significantly decreased
by 10% not earlier than at 28 d.
Fe significantly and continuously increased by 38%
and 39% at 7 and 28 d, respectively, in the interpedun-
cular nucleus. Comparatively slight changes of Fe were
found in the substantia nigra suggesting a u-shaped
kinetics with a roughly 10% decrease at 2 h and 7 d and
compensation to normal levels at 28 d. Zn and Mn
concentrations were equal to control levels at the late
time point following slight initial decreases in the
polymorph layer of the dentate gyrus. No changes were
Table 3. Concentrations of Fe, Cu, Zn, Mn (mean  SD) measu
of mice (18 animals) at different time points after MPTP treatmen
g g-1 wet
weight Control MPTP 2 h MPTP 28 d
Striatum
Fe 3.7  0.5 3.6  0.2 4.2  0.4
Cu 1.6  0.1 1.7  0.2 1.7  0.1
Zn 7.3  0.5 8.4  0.8 7.7  0.5
Mn 0.16  0.04 0.18  0.00 0.17  0.03
S. Nigra
Fe 4.2  0.7 3.8  0.3 3.9  0.2
Cu 1.7  0.3 1.4  0.1 1.6  0.2
Zn 6.6  1.5 5.8  0.3 6.3  0.6
Mn 0.30  0.05 0.20  0.04 0.27  0.01
Cortex
Fe 3.5  0.2 3.7  0.3 3.5  0.3
Cu 1.7  0.2 1.6  0.1 1.7  0.2
Zn 8.3  1.3 8.2  0.7 8.2  0.8
Mn 0.20  0.03 0.20  0.03 0.19  0.04
VP-laHT
Fe 4.3  0.6 4.6  0.4 4.9  0.2
Cu 1.2  0.1 1.2  0.2 1.7  0.5
Zn 6.6  0.5 7.6  0.8 8.2  1.4
Mn 0.26  0.10 0.26  0.03 0.31  0.05
Data are given as mean  standard deviation.
- 	 not significant; ANOVA 	 analysis of variance; VP-laHT 	 ventral p
*A univariate one-way analysis of variance (ANOVA) was used to com
that within-group variances equal between-group variances. P  0.05
**Level of significance yielded from the contrast (1, 1, 1, 1) assum
***Level of significance yielded from the contrast (1, 1, 1, 1) assum
****Level of significance yielded from the contrast (1.5, 0.5, 0.5, 1.observed in C, P, and S.Correlation with Previous Findings
The slight changes of element concentrations observed,
not exceeding 40% compared with controls, were in line
with the mild nature of the subchronic MPTP model
chosen to mimic the slow course of the human disease.
Especially in the PD-related candidate regions, substantia
nigra and striatum element concentrations were almost
constant.
Rios and coworkers [32] studied the identical
MPTP model (5 injections of 30 mg kg1) at d 7 as a
single time point, dissected the mouse brains into
four large parts and analyzed Cu, Mn, and Pb in
digests by atomic absorption spectroscopy (AAS). We
were able to reproduce the tendency to a Cu decrease
in the striatum but not to the extent of 50% (only 10%
here). In the cortex, as in our study, all element
concentrations were constant in a margin of 10%.
Mn showed a 20% versus 7% decrease in the striatum
and, similar to this study, constancy in the cortex and
mesencephalon.
Clearly, considerable changes in small regions such
as the periventricular zone are diluted within these
large fragments. Measurements vary to a great extent
with respect to whether this small zone at the margin
with major Cu contribution is included into the striatal
tissue block or not.
Recently, Salazar and coworkers [33] studied the
y imaging LA-ICP-MS in “large” regions of interest in the brain
sus controls
PTP 7 d
ANOVA
P* global P** increase P*** U-shape
3.9  0.3 - 0.018 -
1.7  0.2 - - -
8.1  1.1 - - -
.18  0.01 - - -
4.4  0.2 0.018 - 0.003
1.6  0.3 - - -
6.3  0.8 - - 0.08
.30  0.04 0.019 - 0.012
3.7  0.3 - - -
1.5  0.2 0.029 0.015**** -
8.0  1.1 - - -
.18  0.03 - - -
4.7  0.7 - - -
1.4  0.3 0.045 0.014 -
8.0  1.7 0.06 0.025 -
.31  0.02 - - -
m and lateral hypothalamus.
group means. P-values as level of significance indicate the probability
onsidered as significant.
two-step increase in the order Ctrl 	 2 h  7 d 	 28 d.
-shaped kinetics in the order Ctrl  2 h 	 7 d  28 d.
uming a continuous decrease in the order Ctrl  2 h  7 d  28 d.red b
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maximum increase of 29% at d 2, they observed an 18%
decrease at d 7 and a 10% increase at d 21.
Figure 3. Sets of individually delineated region
in the anterior series (upper row) and the poster
concentration maps of Fe (left). Microphotogra
anatomical correlation (right). Upper row: AC
region; BST 	 bed nucleus of the stria terminali
composed of corpus callosum and the adjacent
intermediate hypothalamus; LSD 	 lateral septa
piriform CTX 	 piriform cortex; SO 	 nucleus s
defined by Cu enrichment; tubercul. 	 tubercu
hypothalamus. Lower row: 1 	 nucleus interst
APT 	 anterior pretectal nucleus; CA3 	 part 3 o
dorsal portion of CA3 equaling the polymorph la
laterale; Coll. Sup. 	 colliculus superior; cp 	 ce
interpeduncular nucleus; Mes 	 mesencephalon
PAG 	 periaqueductal gray; Ra. 	 nucleus Raph
Figure 4. Quantitative metal images of Cu, Zn,
and 28 d after the last of five daily MPTP injectio
ventricles, the striatum and the hypothalamus.
region at 28 d of MPTP.Fe concentrations of 5–6 g g1 wet weight in
controls were very close to the value of 4 g g1
observed in this study.
interest in coronal mouse brain sections as used
ries (lower row) are exemplified in LA-ICP-MS
f cresyl-violet-stained adjacent sections permit
terior commissure; aThal 	 anterior thalamic
stria terminalis; Ref. 	 reference region for Fe
al layers V and VI; GP 	 globus pallidus; IHT,
leus, dorsal part; MHT 	medial hypothalamus;
opticus; subventricul. 	 periventricular zone as
lfactivum; VP-laHT 	 ventral pallidum-lateral
Cajal; 2 	 nucleus oculomotorius accessorius;
cornu ammonis, ventral portion; CA3/polDG 	
f the gyrus dentatus; CGL 	 corpus geniculatum
l peduncle; dFD 	 dorsal fascia dentate; IPN 	
classified otherwise; Nigra 	 substantia nigra;
. 	 nucleus rubber; vFD 	 ventral fascia dentata.
n representative of each group (control, 2 h, 7 d,
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cessed with modified Prussian blue staining, but only
small details of these sections were shown, not covering
the interpeduncular nucleus. Only mild nigral staining
was described in controls with a restricted localized
increase at 2 d MPTP. Another study assessed Prussian
blue positive cells in controls, 3 and 7 d after acute
MPTP (3 30 mg kg1), which covered 0.3%, 0.4%, and
0.6% of the nigral area respectively [34]. Apparently,
this small fraction would not significantly influence
total nigral Fe content.
Our findings in the subchronic MPTP mouse model
clearly differ from findings in the more aggressive
6-OHDA rat model, where tremendous increases of Fe,
Cu, Zn, and Mn in the basal ganglia were measured by
ICP-MS on dissected tissue fragments [35].
Mechanistic Interpretation
Amongst our findings was an initial decrease of Cu,
reversible in the fascia dentata and with a 40% rebound
in periventricular zones. This could simply result from
an overlay of regions with high Cu content and regions
with high susceptibility to MPTP (vide infra). The
direction of this effect remains to be explained, as well
as the concomitant slight but significant continuous
decrease of Cu in the cortex and brainstem. Therefore, it
must be remembered that on a cellular level, Cu is first
passively taken up by the selective copper transporter
Ctr1 [36, 37] and then actively sequestered by the
ATP-consuming copper efflux pumps ATP1A [37] and
ATP1B [38]. Thus, the transport of Cu across cellular
barriers such as the blood-brain (BBB) and the blood
cerebrospinal fluid (CSF) barrier (BCB) consumes en-
Figure 5. Quantitative metal images of Cu, Zn,
and 28 d after the last of five daily MPTP in
substantia nigra, the interpeduncular nucleus and
aqueduct and of iron in the interpeduncular nuergy. MPTP causes a severe breakdown of the cellularenergy metabolism with a depletion of ATP. It therefore
seems plausible that coinciding with the maximal toxic
effects observed in the initial phase (2 h, 7 d), the
delivery of Cu to the CSF and to the brain parenchyma
is hampered. Recovery or overcompensation in the
periventricular zones may be faster (as early as d 28)
than in the parenchyma (later than d 28) due to the
higher proliferative capacity of the ependyma. The
endothelial transition compartment where Cu should
be entrapped in this scenario is too small to be resolved
by LA-ICP-MS or to measurably influence local aver-
ages. This interpretation is corroborated by histochem-
ical studies localizing abundant ATP7A and ATP7B in
periventricular regions and the fascia dentata [36, 38,
39]—the endothelium of small capillaries exclusively
expressing ATP7B— and studies of Cu turnover using
[67Cu] applied in vivo and autoradiography. These
showed a pattern congruent to the distribution of total
Cu with by far the highest Cu uptake in periventricular
zones and the fascia dentata [40].
In this context, effects observed in the mouse MPTP
model may be noteworthy. Systemically administered
inorganic Cu [41] was protective. The copper ionophore
clioquinol (Figure 1) that increased cerebral Cu availability
was protective [42]. The moderately lipophilic and less
selective copper chelator diethyldithiocarbamate (Figure
1), which is assumed to decrease cerebral Cu availability
and to inhibit superoxide dismutase was deleterious [43].
It seems likely that in parallel to the increase in NADH/
NAD, MPTP causes an increase of Cu/Cu2, result-
ing in a mobilization of Cu from the bound to the free
compartment.
In humans, increased CSF copper levels in PD pa-
n representative of each group (control, 2 h, 7 d,
ns). Sections on a posterior level crossing the
hippocampus. Note the increase of copper in the
at 7 d and 28 d of MPTP.Fe, M
jectio
thetients [44], have been reported, but are not directly in
170 MATUSCH ET AL. J Am Soc Mass Spectrom 2010, 21, 161–171line with the findings on MPTP mice. However, clio-
quinol (Scheme 1) alleviated Alzheimer’s disease [45].
The Fe increase in the interpeduncular nucleus and
hypothalamic areas exemplifies the anatomic differ-
ences of the rodent MPTP model and the primate
situation. MPTP action results from two prerequisites,
the presence of MPTP binding sites, virtually on glial
cells, and the expression of dopamine transporters
on neurons that take up the toxic pyridinium metab-
olite MPP [46, 47]. Receptor binding studies using
[3H]MPTP and autoradiography on brain slices re-
vealed strong binding in the substantia nigra of hu-
mans, but only modest binding in mice, and low
binding in rats. Coincidentally, primates are very sen-
sitive to MPTP, mice less sensitive, and rats largely
resistant. In mice, the hypothalamus and the periaque-
ductal gray were reported to be the regions with highest
[3H]MPTP binding, followed by the nucleus accumbens
and the olfactory tubercle. The interpeduncular nucleus
was not shown [46]. In rats, the highest binding was
observed in the interpeduncular nucleus, locus coer-
uleus, arcuate and periventricular hypothalamic nuclei,
the subfornical organ, and ventricular ependyma [48].
The situation in mice may be elucidated in more detail
by studies of the distribution of monoamine oxidase
(MAO-B), which is assumed to be identical with the
[3H]MPTP binding sites [46–48]. MAO-B, detected by
receptor autoradiography, was found to be most abun-
dant in mouse raphe nuclei, paraventricular thalamic
nuclei, ependyma, choroids plexus, periaqueductal
gray, and in the interpeduncular nucleus [49]. Indeed,
findings obtained by us (unpublished) and others point
to some dopaminergic innervation of the interpeduncu-
lar nucleus, a complex and highly differentiated struc-
ture where cholinergic afferents and glutamatergic out-
put seem to predominate [50, 51]. Amongst possible
causes of regional Fe increase after MPTP, an increased
expression of divalent metal transporter 1 isoform IRE
transporting non-transferrin-bound Fe2 was observed
on dopaminergic neurons and activated microglia [33].
The question is, which are the initial noxious events and
which the secondary compensatory processes.
Conclusions
LA-ICP-MS imaging proved to be a valuable tool in
preclinical research, yielding consistent and statistically
significant results while analyzing treatment effects in a
larger set of samples. LA-ICP-MS imaging has mean-
while reached routine scale. A global mapping of spa-
tial analyte distribution guiding the targeted sampling
of biological material may be advantageous in many
cases. Findings and effects in small substructures may
be diluted if larger structures are studied by dissection
and bulk analysis. Here, micro-local analysis identified
substructures of interest (periventricular zone, interpe-
duncular nucleus) and revealed that the structures of
interest dissected in previous studies (striatum, mesen-
cephalon) were chosen inappropriately. Our findingscontribute an incentive for further pursuing the metal-
lomic approach in research of and drug development
for neurodegenerative diseases.
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